NCT02754362 A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma Status WITHDRAWN Phase PHASE2
NCT02747407 Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors Status COMPLETED Phase N/A
NCT02743078 Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma Status TERMINATED Phase PHASE2
NCT02728024 Assessing Psychosocial and Supportive Care Needs in Patients With Gliomas Status COMPLETED Phase N/A
NCT02717962 Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting Status COMPLETED Phase PHASE2
NCT02717455 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma Status COMPLETED Phase PHASE1
NCT02713984 A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT02689336 Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors Status WITHDRAWN Phase PHASE2
NCT02686229 Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas Status RECRUITING Phase N/A
NCT02658279 Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype Status ACTIVE_NOT_RECRUITING Phase NA
NCT02622620 Study on Neuroepithelial Tumor Grading and Pseudoprogression After Glioma Therapy Using Advanced Functional MRI Techniques Status UNKNOWN Phase N/A
NCT02549833 Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma Status COMPLETED Phase PHASE1
NCT02520882 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Patients With Primary Gliomas Status UNKNOWN Phase EARLY_PHASE1
NCT02520492 Non Invasive Measurements of Intracranial Pressure in Patients With Malignant Glioma Status COMPLETED Phase NA